Matthew F Cusick Selected Research

Ligands

5/2011

Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew F Cusick Research Topics

Disease

3	Virus Diseases (Viral Diseases) 10/2017 - 02/2013
3	Infections 10/2017 - 05/2011
3	Seizures (Absence Seizure) 10/2017 - 02/2013
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2014 - 02/2012
3	Multiple Sclerosis 07/2014 - 07/2013
3	Autoimmune Diseases (Autoimmune Disease) 05/2014 - 02/2012
2	Demyelinating Diseases (Demyelinating Disease) 06/2015 - 01/2014
2	Human Influenza (Influenza) 07/2012 - 11/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2022
1	Renal Insufficiency (Renal Failure) 10/2022
1	Multiple Myeloma 10/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022
1	Epilepsy (Aura) 10/2017
1	Central Nervous System Diseases (CNS Diseases) 07/2016
1	Inflammation (Inflammations) 06/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2014
1	Encephalitis (Encephalitis, Rasmussen) 02/2013

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 10/2022 - 05/2011
3	Interleukin-6 (Interleukin 6)IBA 10/2017 - 02/2013
3	Antiviral Agents (Antivirals)IBA 05/2014 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2014
2	1H-indole-3-carbaldehyde quinolin-8-yl-hydrazoneIBA 07/2014 - 03/2012
1	Immune Checkpoint InhibitorsIBA 01/2024
1	HLA-DRB4 Chains (HLA DRB4)IBA 01/2024
1	daratumumabIBA 10/2022
1	Monoclonal AntibodiesIBA 10/2022
1	Dithiothreitol (Cleland's Reagent)IBA 10/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2022
1	Complement System Proteins (Complement)IBA 01/2017
1	Soybean Proteins (Soy Protein)IBA 07/2016
1	Myelin Proteolipid ProteinIBA 07/2014
1	Insulin-Like PeptidesIBA 01/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013
1	wogoninIBA 02/2013
1	CytokinesIBA 02/2013
1	Minocycline (Cyclops)FDA LinkGeneric 02/2013
1	MitogensIBA 07/2012
1	Interleukin-17 (Interleukin 17)IBA 07/2012
1	AntigensIBA 07/2012
1	Interleukin-22 (IL-22)IBA 07/2012
1	LigandsIBA 05/2011
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2011
1	HLA-DR Antigens (HLA-DR)IBA 11/2009

Therapy/Procedure

3	Therapeutics 10/2017 - 01/2014
1	Immunotherapy 01/2024
1	Donor Selection 10/2022